Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

0.5301 +0.0149 (+2.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 526,101
Open 0.5242
Bid (Size) 0.5200 (10)
Ask (Size) 0.5499 (11)
Prev. Close 0.5152
Today's Range 0.4981 - 0.5400
52wk Range 0.4550 - 17.12
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
~ Nasal Opioid Abuse Being Explored for PF614 ~ 
From Ensysce Biosciences, Inc.
Via AccessWire

Performance

YTD
-87.64%
-87.64%
1 Month
-48.53%
-48.53%
3 Month
-51.37%
-51.37%
6 Month
-66.45%
-66.45%
1 Year
-96.34%
-96.34%

More News

Read More
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
From Ensysce Biosciences, Inc.
Via AccessWire
Ensysce Biosciences Releases 2021 Annual Shareholder Letter
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Exposures Death Intellectual Property Legal
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
Via FinancialNewsMedia
Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK
From Ensysce Biosciences, Inc.
Via AccessWire
Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer
From Ensysce Biosciences, Inc.
Via AccessWire
51 Biggest Movers From Yesterday
Via Benzinga
Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
From Ensysce Biosciences, Inc.
Via AccessWire
Earnings Scheduled For March 31, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
42 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
52 Biggest Movers From Yesterday
Via Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Short Squeeze Stocks: ISIG, RELI and 3 Others Experts Think Are Ready to Pop
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.